• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: Adenovirus and co-infection as a risk factor for severe community-acquired pneumonia in children.

作者信息

Phi Duc Long, To Minh Manh, Le Kieu Dung, Pham Tien Dat, Vu Cao Thanh, Duong Khanh Linh, Dao Thi Loi, Hoang Van Thuan

机构信息

Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.

出版信息

Front Pediatr. 2024 Dec 2;12:1464813. doi: 10.3389/fped.2024.1464813. eCollection 2024.

DOI:10.3389/fped.2024.1464813
PMID:39687709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11646731/
Abstract
摘要

相似文献

1
Commentary: Adenovirus and co-infection as a risk factor for severe community-acquired pneumonia in children.评论：腺病毒及合并感染作为儿童重症社区获得性肺炎的一个危险因素
Front Pediatr. 2024 Dec 2;12:1464813. doi: 10.3389/fped.2024.1464813. eCollection 2024.
2
Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.病毒混合感染和大环内酯类耐药支原体感染对难治性肺炎支原体肺炎患儿的影响。
BMC Infect Dis. 2020 Aug 26;20(1):633. doi: 10.1186/s12879-020-05356-1.
3
Adenovirus and co-infection as a risk factor for severe community-acquired pneumonia in children.腺病毒及合并感染作为儿童重症社区获得性肺炎的一个危险因素。
Front Pediatr. 2024 Jan 31;12:1337786. doi: 10.3389/fped.2024.1337786. eCollection 2024.
4
Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia.肺炎支原体与腺病毒混合感染导致小儿重症社区获得性肺炎
Microbiol Spectr. 2022 Apr 27;10(2):e0002622. doi: 10.1128/spectrum.00026-22. Epub 2022 Mar 21.
5
Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children.人腺病毒合并感染加重儿童肺炎支原体肺炎的严重程度。
BMC Infect Dis. 2020 Jun 16;20(1):420. doi: 10.1186/s12879-020-05152-x.
6
Mycoplasma pneumoniae and community-acquired pneumonia.肺炎支原体与社区获得性肺炎。
Natl Med J India. 2000 Mar-Apr;13(2):66-70.
7
Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.肺炎支原体作为儿童社区获得性肺炎的病原体：临床特征与实验室诊断
Ital J Pediatr. 2014 Dec 18;40:104. doi: 10.1186/s13052-014-0104-4.
8
Time to Mycoplasma Pneumoniae RNA Clearance for Wheezy vs. Non-Wheezy Young Children with Community-Acquired Pneumonia.支原体肺炎 RNA 清除时间与喘息和非喘息的社区获得性肺炎幼儿。
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmaa109.
9
Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey.肺炎支原体和肺炎衣原体在土耳其伊斯坦布尔社区获得性肺炎儿童中的作用。
J Trop Pediatr. 2006 Jun;52(3):173-8. doi: 10.1093/tropej/fml017. Epub 2006 Apr 20.
10
Association of coinfection with adenovirus pneumonia severity in children.腺病毒肺炎严重程度与合并感染的关系。
Allergol Immunopathol (Madr). 2022 Jan 1;50(1):31-36. doi: 10.15586/aei.v50i1.476. eCollection 2022.

引用本文的文献

1
Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications.越南社区获得性肺炎住院儿童遵守国家指南的障碍及影响
Antibiotics (Basel). 2025 Jul 15;14(7):709. doi: 10.3390/antibiotics14070709.

本文引用的文献

1
Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.儿童肺炎支原体肺炎治疗面临的挑战。
Eur J Pediatr. 2024 Jul;183(7):3001-3011. doi: 10.1007/s00431-024-05519-1. Epub 2024 Apr 18.
2
Adenovirus and co-infection as a risk factor for severe community-acquired pneumonia in children.腺病毒及合并感染作为儿童重症社区获得性肺炎的一个危险因素。
Front Pediatr. 2024 Jan 31;12:1337786. doi: 10.3389/fped.2024.1337786. eCollection 2024.
3
Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis.严重肺炎患者中非典型病原体的流行情况：系统评价和荟萃分析。
BMJ Open. 2023 Apr 11;13(4):e066721. doi: 10.1136/bmjopen-2022-066721.
4
The molecular characteristics, diagnosis, and treatment of macrolide-resistant in children.儿童大环内酯类耐药的分子特征、诊断与治疗
Front Pediatr. 2023 Mar 2;11:1115009. doi: 10.3389/fped.2023.1115009. eCollection 2023.
5
A systematic review of the clinical features of pneumonia in children aged 5-9 years: Implications for guidelines and research.儿童肺炎临床特征的系统评价：对指南和研究的启示。
J Glob Health. 2022 Mar 26;12:10002. doi: 10.7189/jogh.12.10002. eCollection 2022.
6
Clinical Characteristics and Etiology of Community-acquired Pneumonia in US Children, 2015-2018.2015 - 2018年美国儿童社区获得性肺炎的临床特征与病因
Pediatr Infect Dis J. 2022 May 1;41(5):381-387. doi: 10.1097/INF.0000000000003475.
7
Pulmonary and Extrapulmonary Manifestations in Hospitalized Children with Mycoplasma Pneumoniae Infection.住院支原体肺炎感染患儿的肺内和肺外表现
Microorganisms. 2021 Dec 10;9(12):2553. doi: 10.3390/microorganisms9122553.
8
Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019.2010-2019 年儿童重症肺炎支原体肺炎需重症监护治疗。
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):281-291. doi: 10.1016/j.jfma.2020.08.018. Epub 2020 Sep 15.
9
Current perspectives on atypical pneumonia in children.儿童非典型肺炎的当前观点
Clin Exp Pediatr. 2020 Dec;63(12):469-476. doi: 10.3345/cep.2019.00360. Epub 2020 Jun 10.
10
The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children.儿童肺炎支原体所致坏死性肺炎的临床特征及危险因素。
BMC Infect Dis. 2020 Jun 1;20(1):391. doi: 10.1186/s12879-020-05110-7.